Patient Information Expert Advisory Group of the Commission on Human Medicines

Remit 
To advise on communication with patients and the public about risk: benefit of medicines, in particular via patient information leaflets and when risk: benefit changes.

To advise on the delivery and monitoring of the strategy to improve the quality of the patient information set out in the Committee on Safety of Medicines Patient Information Working Group report. Always read the leaflet.

To advise on the implementation of new European legislation concerning improvements to patient information, and to advise on European initiatives in the area of patient information including the European Commission’s commitment to report on patient information practice.

To advise the MHRA on ways to facilitate and promote patient reporting and secure further patient engagement in the patient reporting process.


 Meeting dates for 2010
February          June            October
 4  3  5

Membership

To be appointed.


Page last modified: 22 March 2010